Efficacy and Safety of AFQ056 in Reducing L-Dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-Dopa

This study is ongoing, but not recruiting participants.

Study NCT00582673 Information provided by Novartis

First Received: December 21, 2007 Last Updated: May 9, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2008
Estimated Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)